Speculation builds about a deal for Revolution Medicinesnews2026-01-09T12:10:43+00:00January 9th, 2026|Endpoints News|
Enliven’s Phase 1 leukemia pill data look competitive with Novartis and Ternsnews2026-01-09T12:07:40+00:00January 9th, 2026|Endpoints News|
Viking gets commercial chief while other obesity biotechs sell; Novo’s Uli Stilz steps downnews2026-01-09T12:00:54+00:00January 9th, 2026|Endpoints News|
Eli Lilly, Chai Discovery sign AI software dealnews2026-01-09T12:00:23+00:00January 9th, 2026|Endpoints News|
Medipost gets $140M to take Korean stem cell therapy into USnews2026-01-09T11:30:58+00:00January 9th, 2026|Endpoints News|
Gene editing pioneers launch first startup focused on custom CRISPR therapiesnews2026-01-09T11:00:27+00:00January 9th, 2026|Endpoints News|
Aktis lands biotech’s first IPO of 2026, raising $318M for radiopharmaceuticalsnews2026-01-09T02:42:48+00:00January 9th, 2026|Endpoints News|
OpenAI brings ChatGPT to hospitals on the heels of launching consumer health toolnews2026-01-09T01:49:27+00:00January 9th, 2026|Endpoints News|
Sanofi calls rejection of potential MS blockbuster ‘unexpected’news2026-01-08T20:40:39+00:00January 8th, 2026|Endpoints News|
Illumina hires Eric Green as chief medical officernews2026-01-08T20:30:33+00:00January 8th, 2026|Endpoints News|
